Focus Partners Advisor Solutions’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,770
Closed -$1.91M 1279
2025
Q4
$1.91M Buy
18,770
+3,635
+24% +$292K 0.02% 323
2025
Q3
$965K Buy
15,135
+6,819
+82% +$341K 0.01% 537
2025
Q2
$442K Buy
+8,316
New +$422K 0.01% 711
2022
Q4
Sell
-10,788
Closed -$351K 375
2022
Q3
$351K Buy
10,788
+527
+5% +$21.7K 0.02% 277
2022
Q2
$404K Buy
+10,261
New +$549K 0.03% 211
2022
Q1
Sell
-10,220
Closed -$794K 338
2021
Q4
$794K Buy
+10,220
New +$902K 0.17% 47

Other funds holding EXAS

Focus Partners Advisor Solutions's EXAS Position: Q1 2026 in Review

Focus Partners Advisor Solutions sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 18,770 shares — an estimated $1.91M sold.

Focus Partners Advisor Solutions first reported a position in EXAS in Q4 2021 and held it in 6 quarters. The position peaked at $1.91M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Focus Partners Advisor Solutions reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 18,770 Exact Sciences shares in Q1 2026, an estimated $1.91M.
  • Focus Partners Advisor Solutions first reported a position in Exact Sciences in Q4 2021 and held it in 6 quarters.
  • Focus Partners Advisor Solutions's Exact Sciences position peaked at $1.91M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.